ATE128873T1 - Reassortantes rotavirusvakzin. - Google Patents

Reassortantes rotavirusvakzin.

Info

Publication number: ATE128873T1
Authority: AT; Austria
Prior art keywords: rotavirus vaccine; rotavirus; reassortant rotavirus; reassortants; gene encoding
Prior art date: 1987-11-30

Application number

AT88311331T

Other languages

English (en)

Inventor

Stanley A Plotkin

H Fred Clark

Paul Offit

Original Assignee

Wistar Inst

Philadelphia Children Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-11-30

Filing date

1988-11-30

Publication date

1995-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22425038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE128873(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-11-30 Application filed by Wistar Inst, Philadelphia Children Hospital filed Critical Wistar Inst

1995-10-15 Application granted granted Critical

1995-10-15 Publication of ATE128873T1 publication Critical patent/ATE128873T1/de

Links

229940124859 Rotavirus vaccine Drugs 0.000 title 1
239000000427 antigen Substances 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
238000006386 neutralization reaction Methods 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
241000702673 Bovine rotavirus Species 0.000 abstract 1
241000617996 Human rotavirus Species 0.000 abstract 1
241000702670 Rotavirus Species 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Biotechnology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

AT88311331T 1987-11-30 1988-11-30 Reassortantes rotavirusvakzin. ATE128873T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12647787A	1987-11-30	1987-11-30

Publications (1)

Publication Number	Publication Date
ATE128873T1 true ATE128873T1 (de)	1995-10-15

Family

ID=22425038

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88311331T ATE128873T1 (de)	1987-11-30	1988-11-30	Reassortantes rotavirusvakzin.

Country Status (12)

Country	Link
EP (1)	EP0323708B1 (de)
JP (1)	JP2818760B2 (de)
AT (1)	ATE128873T1 (de)
AU (1)	AU618973B2 (de)
CA (1)	CA1303525C (de)
DE (2)	DE122006000071I1 (de)
ES (1)	ES2079358T3 (de)
GR (1)	GR3018262T3 (de)
IL (1)	IL88534A (de)
LU (1)	LU91297I2 (de)
NL (1)	NL300252I2 (de)
ZA (1)	ZA888931B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU618963B2 (en) *	1987-08-07	1992-01-16	Institut Pasteur	Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus
US5626851A (en)	1987-11-30	1997-05-06	The Wistar Institute Of Anatomy And Biology	Rotavirus reassortant vaccine
ATE171208T1 (de) *	1990-07-26	1998-10-15	Wistar Inst	Impfstoff aus reassortiertem rotavirus
US5610049A (en) *	1991-05-01	1997-03-11	The Wistar Institute Of Anatomy And Biology	Human rotavirus HCR3A and method of growing said rotavirus
US5900238A (en) *	1995-07-27	1999-05-04	Immunex Corporation	Vaccine delivery system
KR19990072201A (ko) *	1996-10-18	1999-09-27	무타이 마사히꼬	로타바이러스 항원, 로타바이러스 감염증에 대한백신 및 진단제와 항원 제조방법
CN110903403B (zh) *	2019-12-16	2021-07-13	中国农业大学	一种牛轮状病毒嵌合抗原以及检测牛轮状病毒抗体的胶体金免疫层析试纸卡
KR102374547B1 (ko) *	2021-05-31	2022-03-14	에스케이바이오사이언스(주)	재배열 로타바이러스의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4571385A (en) *	1983-06-27	1986-02-18	The United States Of America As Represented By The Department Of Health And Human Services	Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
US4636385A (en) *	1985-02-15	1987-01-13	The Wistar Institute Of Anatomy & Biology	Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection

1988
- 1988-11-28 AU AU26306/88A patent/AU618973B2/en not_active Expired
- 1988-11-29 CA CA000584371A patent/CA1303525C/en not_active Expired - Lifetime
- 1988-11-29 ZA ZA888931A patent/ZA888931B/xx unknown
- 1988-11-29 IL IL8853488A patent/IL88534A/en active Protection Beyond IP Right Term
- 1988-11-30 DE DE19883854575 patent/DE122006000071I1/de active Pending
- 1988-11-30 JP JP63301117A patent/JP2818760B2/ja not_active Expired - Lifetime
- 1988-11-30 AT AT88311331T patent/ATE128873T1/de active
- 1988-11-30 ES ES88311331T patent/ES2079358T3/es not_active Expired - Lifetime
- 1988-11-30 EP EP88311331A patent/EP0323708B1/de not_active Expired - Lifetime
- 1988-11-30 DE DE3854575T patent/DE3854575T2/de not_active Expired - Lifetime
1995
- 1995-11-30 GR GR950403377T patent/GR3018262T3/el unknown
2006
- 2006-12-14 NL NL300252C patent/NL300252I2/nl unknown
- 2006-12-20 LU LU91297C patent/LU91297I2/fr unknown

Also Published As

Publication number	Publication date
DE122006000071I1 (de)	2007-04-05
ES2079358T3 (es)	1996-01-16
DE3854575T2 (de)	1996-05-15
AU2630688A (en)	1989-06-01
IL88534A0 (en)	1993-12-08
AU618973B2 (en)	1992-01-16
LU91297I2 (fr)	2007-02-20
CA1303525C (en)	1992-06-16
EP0323708B1 (de)	1995-10-11
NL300252I2 (nl)	2007-06-01
JP2818760B2 (ja)	1998-10-30
IL88534A (en)	1994-02-27
EP0323708A1 (de)	1989-07-12
DE3854575D1 (de)	1995-11-16
ZA888931B (en)	1989-07-26
NL300252I1 (nl)	2007-01-01
JPH02138970A (ja)	1990-05-28
GR3018262T3 (en)	1996-02-29

Publication	Publication Date	Title
FI892131A0 (fi)	1989-05-03	Analoger till underenheter av bordetellatoxin, vilka haerstammar fraon hybrid-dna.
NO20015073L (no)	2001-11-22	Vaksiner
DK157087A (da)	1987-03-27	Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
BR9912176A (pt)	2002-11-05	Epìtopos de célula auxiliar t artificial como estimuladores imunes para imunógenos de peptìdeo sintéticos incluindo peptìdeos de lhrh imunogênicos
DK0557427T3 (da)	1998-10-26	Human rotavira, vacciner og fremgangsmåder
DE3854575D1 (de)	1995-11-16	Reassortantes Rotavirusvakzin.
AU3150584A (en)	1985-01-25	Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
Zapikian et al.	1986	Alternative approaches to the development of a rotavirus vaccine.
HU9701586D0 (en)	1997-11-28	Improved inactivated vaccines
DK0493575T3 (da)	1999-06-14	Vaccine af reassortant rotavirus
EP0636030A4 (de)	1996-02-07	Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
FR2796282B1 (fr)	2001-10-26	Vaccin inactive contre la calicivirose feline
EP0293333A3 (en)	1990-09-19	A synthetic nonapeptide of use as an adjuvant
IT1233419B (it)	1992-03-31	Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
Lovgren	1989	Construction and potential of the iscom as immunogen.
Lutz	1986	Feline leukaemia vaccine Leukocell: Rules concerning its application.
Joklik	1984	Antigenic relationships between the proteins of the three serotypes of reovirus.